Timely allopurinol in asymptomatic hyperuricemia: modelling a hypothesis worth prospective investigation. Authors’ reply

András Inotai, Dávid Nagy, Gábor Kovács, Claudio Borghi

Open source

DOI
10.1016/j.ejim.2026.107187
Published
2026-09
Container
European Journal of Internal Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejim.2026.107187,
  title = {Timely allopurinol in asymptomatic hyperuricemia: modelling a hypothesis worth prospective investigation. Authors’ reply},
  author = {András Inotai and Dávid Nagy and Gábor Kovács and Claudio Borghi},
  year = {2026},
  journal = {European Journal of Internal Medicine},
  doi = {10.1016/j.ejim.2026.107187},
  url = {https://doi.org/10.1016/j.ejim.2026.107187}
}

RIS

TY  - JOUR
TI  - Timely allopurinol in asymptomatic hyperuricemia: modelling a hypothesis worth prospective investigation. Authors’ reply
AU  - András Inotai
AU  - Dávid Nagy
AU  - Gábor Kovács
AU  - Claudio Borghi
PY  - 2026
JO  - European Journal of Internal Medicine
DO  - 10.1016/j.ejim.2026.107187
UR  - https://doi.org/10.1016/j.ejim.2026.107187
ER  - 

APA

Inotai, A., Nagy, D., Kovács, G., & Borghi, C. (2026). Timely allopurinol in asymptomatic hyperuricemia: modelling a hypothesis worth prospective investigation. Authors’ reply. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2026.107187

Source records